NCT01025453 Combination of Temsirolimus and Sorafenib in the Treatment of Radioactive Iodine Refractory Thyroid Cancer Status COMPLETED Phase PHASE2
NCT00970359 Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244 Status COMPLETED Phase NA
NCT00954837 Assessment of Repeat Fine Needle Aspiration (FNA) to Detect Thyroid Cancer Status WITHDRAWN Phase NA
NCT00948337 A Study With Health Educational Material on Health Promotion in Cancer Survivors Status UNKNOWN Phase PHASE2
NCT00936858 RAD001 for Patients With Radioiodine Refractory Thyroid Cancer Status COMPLETED Phase PHASE2
NCT00926978 Comparison of Iodine-124 (I-124) and Iodine-131 (I-131) Radiopharmacokinetics in Patients Prepared With Recombinant Human TSH Injection (rhTSH) Status TERMINATED Phase NA
NCT00896454 Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium Status COMPLETED Phase PHASE2
NCT00887107 Sorafenib as Adjuvant to Radioiodine Therapy in Non-Medullary Thyroid Carcinoma Status COMPLETED Phase PHASE2
NCT00804830 Avastin and Doxorubicin Postoperatively for Patients With Anaplastic Thyroid Cancer Status TERMINATED Phase PHASE2
NCT00795782 Prophylactic Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma Status COMPLETED Phase PHASE3
NCT00794053 The Usefulness of Staining Lymph Nodes During Operations for Cancer Thyroid in Detecting the Nodes That Have Cancer Status COMPLETED Phase PHASE3
NCT00786552 Pemetrexed + Paclitaxel in Patients With Recurrent/Advanced Thyroid Cancer Status UNKNOWN Phase PHASE2
NCT00784303 Evaluating the Safety and Efficacy of Oral Lenvatinib in Medullary and Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers, Stratified by Histology Status COMPLETED Phase PHASE2
NCT00719615 Assess Vitamin D Levels in Those With & Without Thyroid Cancer Status COMPLETED Phase N/A
NCT00718770 A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) Expression Status COMPLETED Phase EARLY_PHASE1
NCT00704730 Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer Status COMPLETED Phase PHASE3
NCT00673010 Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma Status COMPLETED Phase PHASE1
NCT00615537 Pilot Study on Laser Ablation of Symptomatic Benign Thyroid Masses Status COMPLETED Phase NA